Modern Solutions for Manufacturing Time-Release Medication
ORLANDO, FL – Dec. 5, 2024 – Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global developer of industrial laser systems for cleaning and other material processing applications, joined by its recently acquired subsidiary, Control Micro Systems, Inc. (CMS), announced today the expansion of its tablet laser drilling technology development program targeting the pharmaceutical and medical technology market.
Tablet laser drilling is a proven, economically viable way to create sub-millimeter apertures in pharmaceutical tablets. This method plays a key role in osmotic pump time-release drug delivery systems, which provide many health benefits like decreasing dosing frequencies, maintaining consistent drug levels in the body over a specific period and enabling customized delivery profiles.
The Tablet Laser Drilling technology by CMS provides an automated, high-speed process capable of drilling up to 140,000 tablets per hour with orifices as small as 200 microns. This technology is engineered to achieve precise dimensional tolerances for osmotic pump tablets and related drug delivery systems, making laser drilling the preferred method for modern pharmaceutical tablet production. Machine vision technology for visual inspection ensures quality and alignment, checking each tablet twice for hole position, size, and/or number before reaching the collection bin. Rejection of produced tablets is rare due to the precision of the system, and any failed tablets are speedily ejected into separate bins.
For LPC, established as a trusted provider of industrial laser equipment, pharmaceutical and medical technologies is a new sector of focus. Supplemented by CMS expertise, LPC is dedicating resources to research and development in this sector in accordance with its broad diversification strategy, poised to contribute to growing shareholder value and foster greater resilience in evolving markets.
“With the expansion of R&D and the integration of CMS expertise, we can rapidly advance our product offerings to meet the high demands of the pharmaceutical industry,” said Wayne Tupuola, CEO of LPC. “Our focus on precision and efficiency is transforming drug delivery systems, ensuring optimal performance and patient safety. We are committed to driving forward the future of pharmaceutical manufacturing with cutting-edge solutions that enhance patient outcomes and streamline production processes.”
For more information, visit the LPC website at www.laserphotonics.com.
About CMS Laser
Control Micro Systems (CMS Laser), is a 40-year U.S. pioneer in software controls development for laser machines. Today, the company produces turnkey laser material processing systems for marking, cutting, drilling, welding, and more. Its cutting-edge laser systems are expertly engineered for high-precision applications in a wide range of industries and tailored to each clients’ unique manufacturing needs. CMS Laser specializes in developing custom laser systems for a wide range of industries, including solutions for slow-release tablets and counterfeit-proof pill manufacturing. It also counts several top 20 global life sciences companies among their customers. For more information, visit CMS Laser, a Laser Photonics company.
About Laser Photonics Corporation
Laser Photonics is a vertically integrated manufacturer and R&D Center of Excellence for industrial laser technologies and systems. Laser Photonics seeks to disrupt the $46 billion, centuries-old sand and abrasives blasting markets, focusing on surface cleaning, rust removal, corrosion control, de-painting and other laser-based industrial applications. Laser Photonics’ new generation of leading-edge laser blasting technologies and equipment also addresses the numerous health, safety, environmental and regulatory issues associated with old methods. As a result, Laser Photonics quickly gained a reputation as an industry leader in industrial laser systems with a brand that stands for quality, technology and product innovation. Currently, world-renowned and Fortune 1000 manufacturers in the aerospace, automotive, defense, energy, maritime, nuclear and space industries are using Laser Photonics’ “unique-to-industry” systems. For more information, visit http://www.localhost:10010.
Cautionary Note Concerning Forward-Looking Statements
This press release contains “forward-looking statements” (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), including statements regarding the Company’s plans, prospects, potential results and use of proceeds. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption “Risk Factors” in the Registration Statement. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.
Investor Relations Contact:
[email protected]
Media Contact:
Karla Kizzort
Marketing Specialist
Laser Photonics Corporation
[email protected]